EUVIMEDSkopri EUVIMED
Crossref

Aneuploidy impairs B cell development but accelerates their MYC-driven transformation

Johannes G Weiss iD, Paul Y Petermann iD, Irene Rigato iD, Michael Lohmüller iD, Felix Honold iD, Marina Schapfl iD, Sarah Spöck iD, Nadine Kinz iD, Andréa E Tijhuis iD, René Wardenaar iD, Marilú Losito iD, Floris Foijer iD and 7 more

Science Advances · 2026-11-13 · 12 (46)

DOI: 10.1126/sciadv.aef2143 ↗

At a glance

Journal article in Science Advances, published on 2026-11-13. Written by Johannes G Weiss and 18 co-authors. Institution: Institute for Developmental Immunology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria. Major MEDLINE topics: Aneuploidy, Cell Transformation, Neoplastic, B-Lymphocytes, Proto-Oncogene Proteins c-myc. 105 references. Funded by: European Research Council, Tyrolean Science Fund, Austrian Science.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Chromosomal instability (CIN) is an established driver of aneuploidy and cell death. Here, we investigate the role of apoptosis as a barrier against CIN-driven aneuploidy in B lymphocytes. We found that impairment of their spindle assembly checkpoint via deletion of Mitotic Arrest Deficient 2-Like 1 or mutation of Monopolar Spindle 1 kinase curtails B cell survival. A CRISPR screen identified intermediates of mitochondrial apoptosis as critical, which we confirmed in vivo by overexpression of a B cell–restricted BCL2 transgene, outperforming loss of P53 . Notably, cell death inhibition by BCL2 was insufficient to cause aneuploidy-driven B cell transformation, while loss of P53 strongly synergized with tumors featuring stochastic aneuploidies. In contrast, high cell death rates rapidly select for specific karyotypes, facilitating aneuploid tumor cell survival in E μ -Myc transgenic mice. Hence, cell death inhibition fails to allow CIN-driven aneuploidies to prevail. In contrast, BCL2-regulated apoptosis selects viable aneuploid tumor karyotypes in the presence of oncogenic MYC, a notion with implications for the clinical use of BCL2-targeting therapies.

Subjects

MeSH terms (MEDLINE)

AneuploidyCell Transformation, NeoplasticB-LymphocytesProto-Oncogene Proteins c-mycAnimalsApoptosisMiceProto-Oncogene Proteins c-bcl-2Tumor Suppressor Protein p53Mice, TransgenicChromosomal Instability

Substances

Proto-Oncogene Proteins c-mycProto-Oncogene Proteins c-bcl-2Tumor Suppressor Protein p53

Authors and institutions

  • Institute for Developmental Immunology, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.
  • Department of Paediatrics I, Medical University of Innsbruck, 6020 Innsbruck, Austria.
  • Department of Molecular Biology, Digital Science Center (DiSC), University of Innsbruck, 6020 Innsbruck, Tyrol, Austria.
  • European Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, A. Deusinglaan 1, Groningen 9713 AV, Netherlands.
  • CeMM Research Center for Molecular Medicine, Austrian Academy of Sciences, 1090 Vienna, Austria.
  • Institute for Bioinformatics, Biocenter, Medical University of Innsbruck, 6020 Innsbruck, Austria.

ORCID profiles: Johannes G Weiss, Paul Y Petermann, Irene Rigato, Michael Lohmüller, Felix Honold, Marina Schapfl, Sarah Spöck, Nadine Kinz, Andréa E Tijhuis, René Wardenaar, Marilú Losito, Floris Foijer, Dario Rizotto, Michael Schubert, Sebastian Herzog, Joel S Riley, Verena Labi, Francesca Finotello, Andreas Villunger

Funding

  • European Research Council
  • Tyrolean Science Fund
  • Austrian Science

Cite

APA

Weiss, J. G., Petermann, P. Y., Rigato, I., Lohmüller, M., Honold, F., Schapfl, M., Spöck, S., Kinz, N., Tijhuis, A. E., Wardenaar, R., Losito, M., Foijer, F., Rizotto, D., Schubert, M., Herzog, S., Riley, J. S., Labi, V., Finotello, F., & Villunger, A. (2026). Aneuploidy impairs B cell development but accelerates their MYC-driven transformation. Science Advances, 12(46). https://doi.org/10.1126/sciadv.aef2143

Vancouver

Weiss JG, Petermann PY, Rigato I, Lohmüller M, Honold F, Schapfl M, et al. Aneuploidy impairs B cell development but accelerates their MYC-driven transformation. Science Advances. 2026;12(46). doi:10.1126/sciadv.aef2143

BibTeX
@article{Weiss2026,
  author = {Weiss, Johannes G and Petermann, Paul Y and Rigato, Irene and Lohmüller, Michael and Honold, Felix and Schapfl, Marina and Spöck, Sarah and Kinz, Nadine and Tijhuis, Andréa E and Wardenaar, René and Losito, Marilú and Foijer, Floris and Rizotto, Dario and Schubert, Michael and Herzog, Sebastian and Riley, Joel S and Labi, Verena and Finotello, Francesca and Villunger, Andreas},
  title = {Aneuploidy impairs B cell development but accelerates their MYC-driven transformation},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {46},
  doi = {10.1126/sciadv.aef2143}
}
Start for free →